Colgate-Palmolive’s second quarter results were met with a cautious market response, as the company’s revenue matched Wall Street’s expectations while non-GAAP profit modestly exceeded consensus. Management attributed the quarter’s performance to continued strength in emerging markets, particularly in India, Brazil, Mexico, and China, as well as resilience in the Hill’s pet nutrition business. However, operating margin contraction and flat sales volumes reflected persistent competitive pressures in the U.S. and the lingering effects of inventory reductions by key retailers. CEO Noel Wallace described the U.S. performance as “not satisfactory,” highlighting the impact of heightened competition and consumer uncertainty on category growth.

Is now the time to buy CL? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Colgate-Palmolive’s Q2 Earnings Call

• Dara Mohsenian (Morgan Stanley) asked about Hill’s pet division resilience and pricing power. CEO Noel Wallace explained that Hill’s is outperforming in a flat U.S. market and emphasized targeted growth in segments like cat and wet food, while cautioning that category pressures persist.
• Peter Grom (UBS) questioned the strength and sustainability of gross margin gains. Wallace and CFO Stan Sutula attributed margin improvements to core business initiatives and pricing, while warning that future quarters would see increased cost pressures as tariff and raw material costs rise.
• Lauren Lieberman (Barclays) explored the volume-price balance for the rest of the year. Wallace responded that volume will become more important in the second half, especially in international markets, but categories are unlikely to rebound sharply.
• Chris Carey (Wells Fargo Securities) probed why Colgate-Palmolive did not raise organic sales guidance. Wallace cited volatility in consumer demand, particularly in North America, and preferred to maintain a prudent outlook despite some positive trends.
• Kaumil Gajrawala (Jefferies) asked about inventory reductions and the Hill’s Prime fresh launch strategy. Wallace said inventory normalization at retailers would be managed carefully and described a methodical, brand-focused rollout for fresh pet food, aiming for professional endorsement before scaling volume.

Catalysts in Upcoming Quarters

In upcoming quarters, the StockStory team will closely monitor (1) the effectiveness of expanded premium product launches and stepped-up advertising in North America, (2) Colgate-Palmolive’s ability to manage margin pressures from raw material and tariff costs, and (3) sustained market share gains in emerging markets and the Hill’s division. Progress in digital transformation and AI-driven efficiency initiatives will also be important markers of execution.

Colgate-Palmolive currently trades at $91.72, in line with $91.60 just before the earnings. Is there an opportunity in the stock? Find out in our full research report (it’s free).

Our Favorite Stocks Right Now

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.